Summary
Twenty-three out of 28 patients with metastatic breast carcinoma and one out of 13 patients with localised disease had raised levels of plasma immunoreactive calcitonin. Monolayer cultures of breast carcinomas maintained for up to 10 weeks released immunoreactive calcitonin, and a primary breast carcinoma passaged in "nude" mice for over a year contained material immunologically and chromatographically resembling the monomeric form of human calcitonin.
These studies indicate that breast carcinomas can produce calcitonin and that plasma calcitonin measurements may be useful in staging patients with breast carcinomas.
Introduction
Extrathyroidal secretion of calcitonin has been suggested by finding increased concentrations of immunologically or biologically active hormone in a variety of endocrine tumours1-3 and an oat-cell carcinoma of the bronchus. 4 table) . Tumour tissue, removed at operation, was immediately placed in medium 199 (Bio-Cult Labs) containing 005% penicillin and 0.0500 streptomycin and delivered to the laboratory within two hours. Contaminating fat and connective tissue were removed. The remaining tumour was cut into 0 5-mm slices which were then reduced to a fine "mince," transferred to a sterile centrifuge tube containing medium 199, shaken manually for five minutes, and then allowed to stand for five minutes. The supernatant containing single and small aggregates of cells was removed with a Pasteur pipette, transferred to a 25-ml Falcon flask, and incubated with 5-ml medium RPM1 1640 with 10% fetal calf serum at 37°C. When the cells had attached (within three days) they were rinsed with medium RPM1 1640 containing 10% lamb serum and refed with this medium, which was replaced every two or three days. The cell-exposed media were stored at -30°C for subsequent calcitonin immunoassay. Selected cultures (1, 2, and 3, see table) were incubated for 24 hours with 10-mM dibutyryl cyclic adenosine monophosphate (AMP) (Sigma) or calcium chloride (7.5 mmol/l (15 mEq/l)).
CULTURE OF BREAST TUMOURS IN IMMUNE-DEFICIENT MICE
Athymic nude mice (obtained from the MRC Laboratory Animal Centre, Carshalton, and Anglia Laboratory Animals) were delivered to our laboratory pathogen-free and were housed in a sterile environment.
A breast tumour (grade 2, infiltrating and intraduct carcinoma) was obtained at operation, and blocks 2 x 2 x 3 mm were implanted subcutaneously into four sites of four female nude mice. These xenografts grew to an average size of 1 cm.3 One mouse was killed seven months after the original implant and a 2 x 2 x 3-mm sample from each graft site was implanted into another nude mouse. After five months further growth had occurred and the tumour was removed and extracted with 0 1-M HCl.8 Control mouse salivary gland and thyroid tissue from 11 BALB-C mice were extracted in a similar manner. A monolayer culture of some of the mouse-grown breast tumour was prepared (see above) and the medium immunoassayed for calcitonin, after incubation with the cells for three days.
CHROMATOGRAPHY
Media from breast carcinoma cultures 9 and 11 (see table) were collected over a week, pooled, and lyophilised after removing material of less than 1000 molecular weight by filtration using AMICON UM2 filters. This material and an extract of mouse-grown breast tumour and control mouse tissue were chromatographed using a G50 Sephadex column (130 x 1 cm) equilibrated with 0 1-M formic acid and 100% isopropanol (pH 2-2). The column was calibrated with dextran 2000 and 125I-labelled synthetic human calcitonin. Fractions were collected at room temperature, lyophilised, and dissolved in 0 05-M phosphate buffer before immunoassay.
IMMUNOASSAY
The immunoassay for plasma calcitonin using an antiserum directed against synthetic human calcitonin has been reported elsewhere. 6 The immunoassay for carcinoembryonic antigen (CEA) has also been described,9 and the method for human chorionic gonadotrophin (HCG) immunoassay was that of Vaitukaitis et al,10 but using Burroughs-Wellcome antiserum RD01. Insulin was measured using a kit (Gruppo Lepetit, Italy).
For tissue culture samples, similar methods were followed but unincubated tissue culture medium was used in the standard curve in the place of plasma. Control culture medium from fibroblasts, incubated under similar conditions to the breast carcinomas, was included in each immunoassay; all samples were assayed in duplicate and in at least two dilutions.
Results

PLASMA IMMUNOREACTIVE CALCITONIN IN PATIENTS
Immunoreactive calcitonin was undetectable (<0 1 ,ug/l) in plasma samples from our control population of 69 subjects6 and in the plasma of 14 Three cultures continued to release hormone for four, six, and ten weeks respectively. In these cultures the rate of production of immunoreactive calcitonin was not altered by incubation with 10-mM dibutyryl cyclic AMP or by increasing the calcium concentrations of the medium incubated with the cells. Two out of six breast carcinomas also produced a material which inhibited the binding of 125I-labelled CEA to anti-CEA, and three out of 12 released immunoreactive HCG. Immunoreactive insulin was not detected in any of the three cultures tested (Ni, 2, and 3).
Gel filtration of medium incubated with breast carcinoma cultures 9 and 11 showed that some immunoreactive material was eluted at a similar position to 125I-labelled calcitonin, some eluted before, and some later, indicating the presence of multiple immunoreactive forms. 
BREAST TUMOUR GROWN IN NUDE MICE
The breast xenograft studied had an identical histological appearance to the specimen removed from the patient at operation one year 199 earlier. The extract contained a material (20 ng/g wet tissue) which, in six dilutions, paralleled the standard curve of synthetic human calcitonin (fig 2b) in the immunoassay. When chromatographed, the immunoreactive material eluted as two peaks, one running before and one coincident with 125I-labelled calcitonin (fig 3) . An extract of control mouse tissue was similarly chromatographed, but no peak of immunoreactivity was found. The extract of mouse thyroid glands contained a material which, in several dilutions, inhibited the binding of "25I-labelled calcitonin to antibody, but, in contrast to the xenograft extract, this inhibition did not parallel that produced by the synthetic standard (fig 2a) . Subsequently monolayer culture of this tumour was shown to release a material which resembled synthetic human calcitonin immunologically (3-5 ,g 1 tissue culture medium -'day-1).
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